Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06429293 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Cognitive Behavioral Therapy on PTSD-CVD Link

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Final enrollment: 6 participants (planned 30) · Eligibility criteria expanded, about 13 words · Site details revised · 1 more Show 4 more changesShow less
    • Final enrollment: 6 participants (planned 30)
    • Eligibility criteria expanded, about 13 words
    • Site details revised
    • Publications: details revised at 46 of 47 entries
  2. Re-verified, no change to tracked fieldsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a pilot randomized controlled trial to assess the impact of a first-line treatment for posttraumatic stress disorder (PTSD) (Cognitive Processing Therapy; CPT) versus waitlist control on mechanisms of cardiovascular disease (CVD) risk. Further, this study will test the hypothesis that CPT reduces CVD risk through its effects on inflammation and autonomic function and that these changes are driven by changes in stress-related neural activity (SNA)
Trial Details
NCT Number NCT06429293
Lead Sponsor Massachusetts General Hospital
Collaborators: American Heart Association
Conditions Posttraumatic Stress Disorder
Enrollment 6 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov